NXTC

NextCure, Inc. NXTC

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 30 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$2.78M total
Ikarian Capital, LLC
$461.3K+21.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$443.5KNew
Sofinnova Ventures Inc
$356.2K0.0%
RENAISSANCE TECHNOLOGIES LLC
$273.9K+182.8%
VANGUARD CAPITAL MANAGEMENT LLC
$250.9KNew
MILLENNIUM MANAGEMENT LLC
$141.0KNew
BOOTHBAY FUND MANAGEMENT, LLC
$135.5K+21.6%
Squadron Capital Management LLC
$103.1K-75.7%
Verdad Advisers, LP
$96.7K+40.7%
PFIZER INC
$73.0K-71.1%
Affinity Asset Advisors, LLC
$67.1K-82.6%
BlackRock, Inc.
$59.8K+34.4%
HRT FINANCIAL LP
$58.0KNew
JANE STREET GROUP, LLC
$52.4KNew
GEODE CAPITAL MANAGEMENT, LLC
$47.9K-3.8%
CARDIFF PARK ADVISORS, LLC
$34.9K0.0%
ACADIAN ASSET MANAGEMENT LLC
$30.0K0.0%
VANGUARD FIDUCIARY TRUST CO
$25.8KNew
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
$20.0KNew
Virtu Financial LLC
$18.0KNew
DIADEMA PARTNERS LP
$12.4KNew
BARCLAYS PLC
$9.2K+1.8%
Persistent Asset Partners Ltd
$3.2KNew
Tower Research Capital LLC (TRC)
$2.8KNew
UBS Group AG
$951+75.7%
See all 30 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/NXTC

Earnings Per Share

13fpro.ai/company/NXTC

Loading ratio trend…

NXTC key financials by period

Reported revenue, net income and operating margin by fiscal year, from NextCure, Inc.'s annual filings on SEC EDGAR.

NextCure, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2020$22.4M$-36.6M-184.2%
FY 2019$6.3M$-33.7M—
Source: NXTC filings on SEC EDGAR →

NXTC insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About NextCure, Inc. (NXTC): stock profile, AI score and financials

NextCure, Inc. (NXTC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NXTC is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 30 institutional filers currently hold this stock. Top institutional holders of NXTC by reported 13-F value include Ikarian Capital, ADAGE CAPITAL PARTNERS GP, L.L.C., Sofinnova Ventures, based on the most recent SEC filings. NXTC trades on the Nasdaq exchange and files with the SEC under CIK 1661059. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NXTC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NextCure, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1661059 →